In the world of medical research, sometimes new discoveries come in unexpected ways. One such discovery is about brain diseases like Parkinson’s, and there’s a hopeful treatment called mild hyperbaric oxygen therapy (mHBOT) that might make a difference.

A Glimpse into Parkinson’s Disease

Parkinson’s is a tough disease where important brain cells break down. These cells control movement and coordination, and when they’re damaged, it causes the symptoms associated with the condition. Researchers are trying to find ways to help, and they’ve found a potential solution in mild hyperbaric oxygen therapy.

The 11-Week Study

In a study that lasted 11 weeks, scientists looked at mHBOT and its effects on brain diseases. They focused on Parkinson’s and found that mHBOT, which involves breathing in oxygen in a pressurized chamber at 1.3 ATA (with a regimen of 3 hours per day, 3 times a week), could slow down the damage to brain cells. The therapy seemed to protect special brain cells and even helped them work better.

Mild hyperbaric oxygen is effective in preventing the progression of Parkinson’s disease.

How Oxygen Therapy Works

The mechanism behind mHBOT’s success lies in its ability to elevate the oxygen content in the blood, particularly in blood plasma. The exposure to mild hyperbaric oxygen at specific atmospheric pressures and oxygen concentrations helps the body’s cells work better and repairs some of the damage that happens in brain diseases. It’s not just for Parkinson’s – it could also help other health problems like metabolic syndrome, arthritis, and issues caused by our lifestyle.


As science continues to unravel the mysteries of mild hyperbaric oxygen therapy, individuals with neurodegenerative diseases are offered renewed hope. The fusion of medical innovation and the body’s innate capacity to heal is revealing a promising path forward—one that could potentially transform the landscape of treatment and care.